General Motors (GM) shares are falling after the company reached a $900 million settlement with the Department of Justice. General Motors (GM) shares are falling after the company reached a $900 ...

Biogen Inc. BIIB and partner Eisai announced that the latter submitted a marketing authorization application seeking approval for their anti-amyloid beta protofibril antibody candidate, lecanemab ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Eisai and Biogen sought the Food and Drug Administration ... that target amyloid to slow a disease that afflicts more than 6 million Americans. In 2021, Biogen's Aduhelm became the first amyloid ...

The land was purchased for around $3.1 million, records show. Back in June, Dave & Buster's filed for a construction permit at 201 Spring Farm Road to build a 22,213-square-foot restaurant ...

"The preliminary result from our investigation indicates that the bad actor(s) obtained data from this API for approximately 37 million current postpaid and prepaid customer accounts, though many ...

Biopharmaceutical company Biogen has picked a new CEO, former Sanofi CEO Christopher Viehbacher, amid fallout from its failed Alzheimer's drug launch. Department of Health and Human Services ...

Kano State Governor, Abdullahi Ganduje, has explained that the Ruga Settlement established by the federal government failed, because was conceived out of misconception. He contended that mass ...

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...